Jefferies Group's IBB Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 302,307 shares of iShares Biotechnology ETF (IBB) worth $51.04 M, representing 0.35% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in IBB, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 450,807 shares. Largest reduction occurred in Q4 2025, reducing 150,349 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's iShares Biotechnology ETF (IBB) Holding Value Over Time
Track share changes against reported price movement
Quarterly iShares Biotechnology ETF (IBB) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1,849 | Add 0.62% | 302,307 | $168.85 |
| Q4 2025 | -150,349 | Reduce 33.35% | 300,458 | $168.77 |
| Q3 2025 | +450,807 | New Buy | 450,807 | $144.37 |
| Q1 2025 | -3,806 | Sold Out | 0 | $0.00 |
| Q4 2024 | +345 | Add 9.97% | 3,806 | $132.22 |
| Q3 2024 | -900 | Reduce 20.64% | 3,461 | $145.61 |
| Q2 2024 | -18,115 | Reduce 80.60% | 4,361 | $137.25 |
| Q1 2024 | +21,616 | Add 2513.49% | 22,476 | $137.22 |
| Q4 2023 | +347 | Add 67.64% | 860 | $135.90 |
| Q1 2023 | -135,000 | Reduce 99.62% | 513 | $129.16 |
| Q4 2022 | +135,513 | New Buy | 135,513 | $131.29 |
Jefferies Group's iShares Biotechnology ETF Investment FAQs
Jefferies Group first purchased iShares Biotechnology ETF (IBB) in Q4 2022, acquiring 135,513 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held iShares Biotechnology ETF (IBB) for 13 quarters since Q4 2022.
Jefferies Group's largest addition to iShares Biotechnology ETF (IBB) was in Q3 2025, adding 450,807 shares worth $65.08 M.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 302,307 shares of iShares Biotechnology ETF (IBB), valued at approximately $51.04 M.
As of the Q1 2026 filing, iShares Biotechnology ETF (IBB) represents approximately 0.35% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in iShares Biotechnology ETF (IBB) was 450,807 shares, as reported at the end of Q3 2025.